![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,2',5,5'-tetrachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of DOK5 mRNA | CTD | PMID:33387578 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1343098 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DOK5 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | decreases expression | ISO | RGD:1623113 | 6480464 | bis(4-hydroxyphenyl)sulfone results in decreased expression of DOK5 mRNA | CTD | PMID:30951980 | 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of DOK5 mRNA | CTD | PMID:24780913 | 8-Br-cAMP | increases expression | ISO | RGD:1343098 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DOK5 mRNA | CTD | PMID:22079614 | acrylamide | increases expression | ISO | RGD:1343098 | 6480464 | Acrylamide results in increased expression of DOK5 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases methylation | ISO | RGD:1343098 | 6480464 | Aflatoxin B1 results in decreased methylation of DOK5 gene | CTD | PMID:27153756 | Aflatoxin B2 alpha | increases methylation | ISO | RGD:1343098 | 6480464 | aflatoxin B2 results in increased methylation of DOK5 intron | CTD | PMID:30157460 | antirheumatic drug | increases expression | ISO | RGD:1343098 | 6480464 | Antirheumatic Agents results in increased expression of DOK5 mRNA | CTD | PMID:24449571 | arsenite(3-) | increases methylation | ISO | RGD:1343098 | 6480464 | arsenite results in increased methylation of DOK5 promoter | CTD | PMID:23974009 | arsenous acid | increases expression | ISO | RGD:1343098 | 6480464 | Arsenic Trioxide results in increased expression of DOK5 mRNA | CTD | PMID:20458559 | belinostat | increases expression | ISO | RGD:1343098 | 6480464 | belinostat results in increased expression of DOK5 mRNA | CTD | PMID:26272509 | benzo[a]pyrene | increases expression | ISO | RGD:1623113 | 6480464 | Benzo(a)pyrene results in increased expression of DOK5 mRNA | CTD | PMID:14625279 | benzo[a]pyrene | affects methylation | ISO | RGD:1343098 | 6480464 | Benzo(a)pyrene affects the methylation of DOK5 exon more ... | CTD | PMID:27901495, PMID:30157460 | benzo[a]pyrene | multiple interactions | ISO | RGD:1623113 | 6480464 | [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of DOK5 mRNA] | CTD | PMID:14625279 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of DOK5 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | RGD:1623113 | 6480464 | bisphenol A results in decreased expression of DOK5 mRNA | CTD | PMID:35598803 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of DOK5 mRNA | CTD | PMID:30816183, PMID:32528016 | bisphenol A | multiple interactions | ISO | RGD:1343098 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DOK5 mRNA | CTD | PMID:28628672 | cadmium atom | decreases expression | ISO | RGD:1343098 | 6480464 | Cadmium results in decreased expression of DOK5 mRNA | CTD | PMID:24376830 | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of DOK5 promoter | CTD | PMID:22457795 | calcitriol | increases expression | ISO | RGD:1343098 | 6480464 | Calcitriol results in increased expression of DOK5 mRNA | CTD | PMID:26485663 | CGP 52608 | multiple interactions | ISO | RGD:1343098 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to DOK5 gene] | CTD | PMID:28238834 | clothianidin | decreases expression | ISO | RGD:1343098 | 6480464 | clothianidin results in decreased expression of DOK5 mRNA | CTD | PMID:31626844 | DDT | increases methylation | EXP | | 6480464 | DDT results in increased methylation of DOK5 gene | CTD | PMID:30207508 | dexamethasone | multiple interactions | ISO | RGD:1343098 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DOK5 mRNA | CTD | PMID:28628672 | diarsenic trioxide | increases expression | ISO | RGD:1343098 | 6480464 | Arsenic Trioxide results in increased expression of DOK5 mRNA | CTD | PMID:20458559 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of DOK5 mRNA | CTD | PMID:21266533 | dorsomorphin | multiple interactions | ISO | RGD:1343098 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | ISO | RGD:1343098 | 6480464 | Endosulfan results in decreased expression of DOK5 mRNA | CTD | PMID:26615145 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of DOK5 mRNA | CTD | PMID:29391264 | ethanol | affects expression | ISO | RGD:1623113 | 6480464 | Ethanol affects the expression of DOK5 mRNA | CTD | PMID:30319688 | folic acid | increases expression | ISO | RGD:1623113 | 6480464 | Folic Acid results in increased expression of DOK5 mRNA | CTD | PMID:25629700 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of DOK5 mRNA | CTD | PMID:33387578 | indometacin | multiple interactions | ISO | RGD:1343098 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DOK5 mRNA | CTD | PMID:28628672 | levonorgestrel | multiple interactions | ISO | RGD:1343098 | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DOK5 mRNA | CTD | PMID:19074003 | methylmercury chloride | decreases expression | ISO | RGD:1343098 | 6480464 | methylmercuric chloride results in decreased expression of DOK5 mRNA | CTD | PMID:28001369 | nickel atom | increases expression | ISO | RGD:1343098 | 6480464 | Nickel results in increased expression of DOK5 mRNA | CTD | PMID:24768652 | nitrofen | increases expression | EXP | | 6480464 | nitrofen results in increased expression of DOK5 mRNA | CTD | PMID:33484710 | panobinostat | multiple interactions | ISO | RGD:1343098 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOK5 mRNA | CTD | PMID:27188386 | paracetamol | decreases expression | ISO | RGD:1343098 | 6480464 | Acetaminophen results in decreased expression of DOK5 mRNA | CTD | PMID:26690555 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of DOK5 mRNA | CTD | PMID:33387578 | PCB138 | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | potassium chromate | multiple interactions | ISO | RGD:1623113 | 6480464 | [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of DOK5 mRNA] | CTD | PMID:14625279 | potassium dichromate | multiple interactions | ISO | RGD:1623113 | 6480464 | [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of DOK5 mRNA] | CTD | PMID:14625279 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of DOK5 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | RGD:1343098 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | RGD:1343098 | 6480464 | Silicon Dioxide analog results in increased expression of DOK5 mRNA | CTD | PMID:23806026 | sodium arsenite | decreases expression | ISO | RGD:1343098 | 6480464 | sodium arsenite results in decreased expression of DOK5 mRNA | CTD | PMID:29301061, PMID:34032870 | sunitinib | increases expression | ISO | RGD:1343098 | 6480464 | Sunitinib results in increased expression of DOK5 mRNA | CTD | PMID:31533062 | testosterone undecanoate | increases expression | ISO | RGD:1343098 | 6480464 | testosterone undecanoate results in increased expression of DOK5 mRNA | CTD | PMID:19074003 | testosterone undecanoate | multiple interactions | ISO | RGD:1343098 | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DOK5 mRNA | CTD | PMID:19074003 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of DOK5 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | RGD:1343098 | 6480464 | trichostatin A results in increased expression of DOK5 mRNA | CTD | PMID:24935251, PMID:26272509 | trichostatin A | multiple interactions | ISO | RGD:1343098 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOK5 mRNA | CTD | PMID:27188386 | valproic acid | decreases methylation | ISO | RGD:1343098 | 6480464 | Valproic Acid results in decreased methylation of DOK5 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | RGD:1343098 | 6480464 | Valproic Acid affects the expression of DOK5 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | RGD:1343098 | 6480464 | Valproic Acid results in decreased expression of DOK5 mRNA | CTD | PMID:29154799 | valproic acid | increases expression | ISO | RGD:1343098 | 6480464 | Valproic Acid results in increased expression of DOK5 mRNA | CTD | PMID:23179753 more ... | vorinostat | multiple interactions | ISO | RGD:1343098 | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOK5 mRNA | CTD | PMID:27188386 | |